Tamara van Donge

Kidney injury biomarkers in pediatrics 185 9 References 1. Siew ED, Ware LB, Ikizler TA. Biological markers of acute kidney injury. Journal of the American Society of Nephrology. 2011;22(5):810-820. 2. Greenberg JH, Parikh CR. Biomarkers for diagnosis and prognosis of AKI in children: one size does not fit all. Clinical Journal of the American Society of Nephrology. 2017;12(9):1551-1557. 3. Libório AB, Branco KMPC, Torres de Melo Bezerra C. Acute kidney injury in neonates: from urine output to new biomarkers. BioMed research international. 2014;2014. 4. Maachi M, Fellahi S, Regeniter A, et al. Patterns of proteinuria: urinary sodium dodecyl sulfate electrophoresis versus immunonephelometric protein marker measurement followed by interpretation with the knowledge-based systemMDI-LabLink. Clinical chemistry. 2004;50(10):1834- 1837. 5. Redahan L, Murray PT. Novel Biomarkers of Drug‐Induced Kidney Injury. Clinical Pharmacology & Therapeutics. 2018;103(3):396-398. 6. Steubl D, Block M, Herbst V, et al. Plasma uromodulin correlates with kidney function and identifies early stages in chronic kidney disease patients. Medicine. 2016;95(10). 7. Devuyst O, Olinger E, Rampoldi L. Uromodulin: from physiology to rare and complex kidney disorders. Nature Reviews Nephrology. 2017;13(9):525. 8. Regeniter A, Freidank H, Dickenmann M, Boesken WH, Siede WH. Evaluation of proteinuria and GFR to diagnose and classify kidney disease: systematic review and proof of concept. European journal of internal medicine. 2009;20(6):556-561. 9. Strimbu K, Tavel JA. What are biomarkers? Current Opinion in HIV and AIDS. 2010;5(6):463. 10. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. Journal of the American Society of Nephrology. 2009;20(3):629-637. 11. Askenazi DJ, Montesanti A, Hunley H, et al. Urine biomarkers predict acute kidney injury and mortality in very low birth weight infants. The Journal of pediatrics. 2011;159(6):907-912. e901. 12. Beker BM, Corleto MG, Fieiras C, Musso CG. Novel acute kidney injury biomarkers: their characteristics, utility and concerns. International urology and nephrology. 2018;50(4):705-713. 13. Westhoff JH, Tönshoff B, Waldherr S, et al. Urinary tissue inhibitor of metalloproteinase-2 (TIMP- 2) • insulin-like growth factor-binding protein 7 (IGFBP7) predicts adverse outcome in pediatric acute kidney injury. PLoS One. 2015;10(11):e0143628. 14. Bojan M, Duarte MCB, Ermak N, Lopez-Lopez V, Mogenet A, Froissart M. Structural equation modelling exploration of the key pathophysiological processes involved in cardiac surgery- related acute kidney injury in infants. Critical Care. 2016;20(1):171. 15. Hassinger AB, Garimella S, Wrotniak BH, Freudenheim JL. The current state of the diagnosis and management of acute kidney injury by pediatric critical care physicians. Pediatric critical care medicine. 2016;17(8):e362-e370. 16. Meersch M, Schmidt C, Van Aken H, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery. PloS one. 2014;9(10):e110865. 17. Mussap M, Noto A, Fanos V, Van Den Anker JN. Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology. BioMed research international. 2014;2014. 18. Bennett MR, Nehus E, Haffner C, Ma Q, Devarajan P. Pediatric reference ranges for acute kidney injury biomarkers. Pediatric nephrology. 2015;30(4):677-685.